For Menopausal Hormone Therapy and Stroke Risk, Timing Makes a Difference
New NHS results corroborate previous findings about HT and stroke risk while providing reassurance for young menopausal women using HT for fewer than 5 years.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)